These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38863627)

  • 21. RERG suppresses cell proliferation, migration and angiogenesis through ERK/NF-κB signaling pathway in nasopharyngeal carcinoma.
    Zhao W; Ma N; Wang S; Mo Y; Zhang Z; Huang G; Midorikawa K; Hiraku Y; Oikawa S; Murata M; Takeuchi K
    J Exp Clin Cancer Res; 2017 Jun; 36(1):88. PubMed ID: 28659184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma.
    Cheng Y; Ho RL; Chan KC; Kan R; Tung E; Lung HL; Yau WL; Cheung AK; Ko JM; Zhang ZF; Luo DZ; Feng ZB; Chen S; Guan XY; Kwong D; Stanbridge EJ; Lung ML
    Oncogene; 2015 Aug; 34(32):4219-28. PubMed ID: 25347745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.
    Dochi H; Kondo S; Komura S; Moriyama-Kita M; Komori T; Nanbo A; Sakaguchi M; Fukuyo M; Hamabe-Horiike T; Tanaka M; Mizokami H; Kano M; Kitagawa Y; Kobayashi E; Hirai N; Ueno T; Nakanishi Y; Endo K; Sugimoto H; Hanayama R; Kaneda A; Yoshizaki T
    Int J Cancer; 2024 Mar; 154(5):895-911. PubMed ID: 37907830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.
    Klibi J; Niki T; Riedel A; Pioche-Durieu C; Souquere S; Rubinstein E; Le Moulec S; Guigay J; Hirashima M; Guemira F; Adhikary D; Mautner J; Busson P
    Blood; 2009 Feb; 113(9):1957-66. PubMed ID: 19005181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV.
    Ahmed N; Abusalah MAHA; Farzand A; Absar M; Yusof NY; Rabaan AA; AlSaihati H; Alshengeti A; Alwarthan S; Alsuwailem HS; Alrumaih ZA; Alsayyah A; Yean CY
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes.
    Liu H; Tang L; Li Y; Xie W; Zhang L; Tang H; Xiao T; Yang H; Gu W; Wang H; Chen P
    Mol Cancer; 2024 Jan; 23(1):20. PubMed ID: 38254110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockage of store-operated Ca
    Ye J; Huang J; He Q; Zhao W; Zhou X; Zhang Z; Li Y; Wei J; Zhang J
    Cancer Manag Res; 2018; 10():1115-1124. PubMed ID: 29785139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.
    Cai L; Ye Y; Jiang Q; Chen Y; Lyu X; Li J; Wang S; Liu T; Cai H; Yao K; Li JL; Li X
    Nat Commun; 2015 Jul; 6():7353. PubMed ID: 26135619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revealing the crosstalk between nasopharyngeal carcinoma and immune cells in the tumor microenvironment.
    Jiang J; Ying H
    J Exp Clin Cancer Res; 2022 Aug; 41(1):244. PubMed ID: 35964134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1.
    Wu Y; Zhang X; Liu C; Li Z; Wen Y; Zheng R; Xu C; Tian J; Wei L; Wang J; Yan Q; Zheng X; Ma J
    J Biol Chem; 2023 Sep; 299(9):105082. PubMed ID: 37495108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasopharyngeal Carcinoma: The Role of the EGFR in Epstein-Barr Virus Infection.
    Peng X; Zhou Y; Tao Y; Liu S
    Pathogens; 2021 Aug; 10(9):. PubMed ID: 34578147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early detection of nasopharyngeal carcinoma.
    Tabuchi K; Nakayama M; Nishimura B; Hayashi K; Hara A
    Int J Otolaryngol; 2011; 2011():638058. PubMed ID: 21716698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.
    Lu J; Liu QH; Wang F; Tan JJ; Deng YQ; Peng XH; Liu X; Zhang B; Xu X; Li XP
    J Exp Clin Cancer Res; 2018 Jul; 37(1):147. PubMed ID: 30001734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year disease-free survival of Epstein-Barr virus-associated locoregionally advanced undifferentiated nasopharyngeal carcinoma patients treated with chemo-radiotherapy: a case report.
    Wang N; Wang H; Jiang H; Bi Y; Zhao Y; He X; Cao F; Yuan Y
    Ann Palliat Med; 2022 Mar; 11(3):1147-1152. PubMed ID: 35365045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flavokawain C inhibits glucose metabolism and tumor angiogenesis in nasopharyngeal carcinoma by targeting the HSP90B1/STAT3/HK2 signaling axis.
    Hu Y; Yu C; Cheng L; Zhong C; An J; Zou M; Liu B; Gao X
    Cancer Cell Int; 2024 May; 24(1):158. PubMed ID: 38711062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNAs in nasopharyngeal carcinoma.
    Yang M; Huang W
    Clin Chim Acta; 2020 Sep; 508():240-248. PubMed ID: 32417214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus noncoding RNAs from the extracellular vesicles of nasopharyngeal carcinoma (NPC) cells promote angiogenesis via TLR3/RIG-I-mediated VCAM-1 expression.
    Cheng S; Li Z; He J; Fu S; Duan Y; Zhou Q; Yan Y; Liu X; Liu L; Feng C; Zhang L; He J; Deng Y; Sun LQ
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1201-1213. PubMed ID: 30659926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigational drugs for nasopharyngeal carcinoma.
    Ma BBY; Hui EP; Chan ATC
    Expert Opin Investig Drugs; 2017 Jun; 26(6):677-685. PubMed ID: 28446055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guggulsterone Promotes Nasopharyngeal Carcinoma Cells Exosomal Circfip1L1 to Mediate miR-125a-5p/VEGFA Affecting Tumor Angiogenesis.
    Zhou T; Zhao S; Tang S; Wang Y; Wu R; Zeng X; Yang P; Zhang X; Tian X
    Curr Mol Pharmacol; 2023; 16(8):870-880. PubMed ID: 36635928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.